title: Discrepancy between antithrombin activity methods revealed in Antithrombin Stockholm: do factor Xa-based methods overestimate antithrombin activity in some patients?
authors.forename: Johanna S
authors.initials: JS
authors.lastname: Ungerstedt
authors.forename: Sam
authors.initials: S
authors.lastname: Schulman
authors.forename: Nils
authors.initials: N
authors.lastname: Egberg
authors.forename: Jovan
authors.initials: J
authors.lastname: Antovic
authors.forename: Nargareta
authors.initials: N
authors.lastname: Blombäck
mesh_terms: D000818:Animals; D000990:Antithrombin III; D000991:Antithrombins / Q000172:deficiency / Q000235:genetics* / Q000378:metabolism; D001778:Blood Coagulation Disorders / Q000175:diagnosis* / Q000235:genetics; D001780:Blood Coagulation Tests / Q000379:methods / Q000592:standards; D002417:Cattle; D003951:Diagnostic Errors; D005260:Female; D006801:Humans; D007202:Indicators and Reagents / Q000592:standards; D008297:Male; D017354:Point Mutation
chemical_list: D000991:Antithrombins; D007202:Indicators and Reagents; C073583:antithrombin III Stockholm; D000990:Antithrombin III